CDEK
← All drugs Report issue

cd22 car-t cells

Cell therapyexperimental

Clinical trial activity

39 trials · 34 clinical orgs · 0 marketing orgs

Phase 1
36
Phase 2
15
Phase 3
0
Phase 4
0

Earliest trial started Nov 20, 2014 (NCT02315612)

Timeline

2010s

  1. Jan 1, 2014

    Earliest Phase 1 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 2 Sponsor(trial)

Indications

Studied for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Also known as

  • anti-cd22 car nk cells
  • cd22 car-t
  • retroviral vector-transduced autologous t cells to express cd22-specific cars

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT07135466Phase 1/Phase 2 (Phase 2)Nov 1, 2025Tel Aviv University
NCT07108868Phase 1Jun 23, 2025University of Tuebingen
NCT06326008Phase 1Dec 15, 2024Government of China
NCT06445803Phase 1May 31, 2024Fudan University, Government of China
NCT06408194Phase 1May 13, 2024Stanford University
NCT06343090N/AApr 12, 2024Government of China
NCT06340737Phase 1Mar 29, 2024Stanford University, The Leukemia and Lymphoma Society
NCT05674175Phase 1/Phase 2 (Phase 2)Jan 25, 2023University of Pennsylvania
NCT05651100Phase 1/Phase 2 (Phase 2)Dec 10, 2022Kecellitics Biotech Company Ltd
NCT05651178Early Phase 1 (Phase 1)Aug 12, 2022Hrain Biotechnology Co., Ltd., Nanchang University
NCT05223686Phase 1Feb 10, 2022Hrain Biotechnology Co., Ltd., Jiao Tong University
NCT04815356Phase 1Dec 7, 2021National Cancer Institute (NCI)
NCT04782193Phase 1/Phase 2 (Phase 2)May 23, 2021Chongqing Medical University, Chongqing Precision Biotech Co., Ltd, People's Liberation Army of China
NCT04781634Phase 1/Phase 2 (Phase 2)Mar 7, 2021Chongqing Medical University, Chongqing Precision Biotech Co., Ltd, People's Liberation Army of China
NCT04788472Phase 1/Phase 2 (Phase 2)Mar 5, 2021Yake Biotechnology Ltd., Zhejiang University
NCT04740203Phase 1/Phase 2 (Phase 2)Jan 31, 2021Yake Biotechnology Ltd., Zhejiang University
NCT04723901Phase 1/Phase 2 (Phase 2)Oct 20, 2020Shenzhen University
NCT04546906N/ASep 1, 2020Hebei Senlang Biotechnology Inc., Ltd., Ludaopei Hospital
NCT04648475Phase 1/Phase 2 (Phase 2)Aug 25, 2020Chongqing Medical University, Chongqing Precision Biotech Co., Ltd
NCT04340167Phase 2May 1, 2020Beijing Boren Hospital
Showing 20 of 39 trials
Page 1 / 2

Organizations

Research & Development (34)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
People's Liberation Army of ChinaGovernment6322016
Chongqing Medical UniversityAcademic/Hospital5022019
Chongqing Precision Biotech Co., LtdFor profit4412019
Government of ChinaGovernment4222019
Hebei Senlang Biotechnology Inc., Ltd.For profit4422020
Stanford UniversityAcademic/Hospital4412020
Hebei UniversityAcademic/Hospital3012020
Anhui Medical UniversityAcademic/Hospital2012018
Hrain Biotechnology Co., Ltd.For profit2212022
Kecellitics Biotech Company LtdGovernment2212019
Ludaopei HospitalAcademic/Hospital2022019
National Cancer Institute (NCI)Government2212014
PersonGen BioTherapeutics (Suzhou) Co., Ltd.For profit2212018
University of PennsylvaniaAcademic/Hospital2222018
Xuzhou Medical UniversityAcademic/Hospital2122016
Yake Biotechnology Ltd.Government2012021
Zhejiang UniversityAcademic/Hospital2212021
Allife Medical Science and Technology Co., Ltd.For profit1112018
Autolus LimitedFor profit1112017
Beijing Boren HospitalAcademic/Hospital1112020
34 organizations
Page 1 / 2